Search Results - Hagop Kantarjian

Hagop Kantarjian

Hagop Kantarjian is a hematologist and oncologist specializing in leukemia. He is a Professor and Chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center, where he holds the Samsung Distinguished Leukemia Chair in Cancer Medicine. Provided by Wikipedia
  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    PTPN11 mutations define a rare but highly adverse subset of myelodysplastic syndromes

    PTPN11 mutations define a rare but highly adverse subset of myelodysplastic syndromes by Alexandre Bazinet, Alex Bataller, Guillermo Montalban-Bravo, Kelly Chien, Koji Sasaki, Wei Ying Jen, Mahesh Swaminathan, Tapan Kadia, Courtney DiNardo, Farhad Ravandi, Guillermo Garcia-Manero, Hagop Kantarjian

    Published 2025-07-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Lower-intensity chemo-immunotherapy with cladribine, low-dose cytarabine, venetoclax and blinatumomab produces high response rates in patients with <i>BCR::ABL1</i>-negative B-cell / myeloid mixed phenotype acute leukemia

    Lower-intensity chemo-immunotherapy with cladribine, low-dose cytarabine, venetoclax and blinatumomab produces high response rates in patients with <i>BCR::ABL1</i>-negative B-cell... by Roberta S. Azevedo, Wei-Ying Jen, Danielle Hammond, Fadi G. Haddad, Alexis Geppner, Ghayas C. Issa, Koji Sasaki, Jayastu Senapati, Elias Jabbour, Farhad Ravandi, Hagop Kantarjian, Tapan M. Kadia

    Published 2025-06-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: